메뉴 건너뛰기




Volumn 4, Issue 1, 2009, Pages 121-136

Diagnosis and management of osteoporosis in the older senior

Author keywords

Aged; Diphosphonates; Eighty and over; Elderly; Osteoporosis; Senior

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; CONJUGATED ESTROGEN; ERGOCALCIFEROL; IBANDRONIC ACID; MEDROXYPROGESTERONE ACETATE; OMEPRAZOLE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; RISEDRONIC ACID; STRONTIUM; STRONTIUM RANELATE; VITAMIN D; ZOLEDRONIC ACID;

EID: 66349121782     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s4965     Document Type: Review
Times cited : (49)

References (137)
  • 1
    • 0036606093 scopus 로고    scopus 로고
    • Diagnosis of osteoporosis and assessment of fracture risk
    • Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359(9321):1929-1936.
    • (2002) Lancet , vol.359 , Issue.9321 , pp. 1929-1936
    • Kanis, J.A.1
  • 2
    • 14744295128 scopus 로고    scopus 로고
    • National Health and Nutrition Examination Survey Osteoporosis Data Brief 12/02, Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, Cited 2009 Jan 9, Available from
    • National Health and Nutrition Examination Survey Osteoporosis Data Brief 12/02. Osteoporosis. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [Cited 2009 Jan 9.] Available from: http://www.cdc.gov/nchs/ data/nhanes/databriefs/osteoporosis.pdf
    • Osteoporosis
  • 3
    • 0028968710 scopus 로고
    • Prevalence of low femoral bone density in older US women from NHANES III
    • Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older US women from NHANES III. J Bone Miner Res. 1995;10(5):796-802.
    • (1995) J Bone Miner Res , vol.10 , Issue.5 , pp. 796-802
    • Looker, A.C.1    Johnston Jr, C.C.2    Wahner, H.W.3
  • 5
    • 66349086841 scopus 로고    scopus 로고
    • Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC: National Osteoporosis Foundation; c2008 [updated 2008 Feb 21; cited 2009 Jan 9]. Available from: http://www.nof.org/professionals/ NOF_Clinicians_Guide.pdf.
    • Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington DC: National Osteoporosis Foundation; c2008 [updated 2008 Feb 21; cited 2009 Jan 9]. Available from: http://www.nof.org/professionals/ NOF_Clinicians_Guide.pdf.
  • 6
    • 66349131420 scopus 로고    scopus 로고
    • Facts and statistics about osteoporosis and its impact, c, cited 2009 Jan 9. Available from
    • Facts and statistics about osteoporosis and its impact. International Osteoporosis Foundation; c 1999-2007; cited 2009 Jan 9. Available from: http://www.iofbonehealth.org/facts-and-statistics.html.
    • International Osteoporosis Foundation , vol.1999-2007
  • 7
    • 0026515737 scopus 로고    scopus 로고
    • Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221-227.
    • Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221-227.
  • 8
    • 0028963682 scopus 로고
    • Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group
    • Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767-773.
    • (1995) N Engl J Med , vol.332 , Issue.12 , pp. 767-773
    • Cummings, S.R.1    Nevitt, M.C.2    Browner, W.S.3
  • 9
    • 0025357992 scopus 로고
    • Hip fracture incidence among the old and very old: A population-based study of 745,435 cases
    • Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health. 1990;80(7):871-873.
    • (1990) Am J Public Health , vol.80 , Issue.7 , pp. 871-873
    • Jacobsen, S.J.1    Goldberg, J.2    Miles, T.P.3    Brody, J.A.4    Stiers, W.5    Rimm, A.A.6
  • 10
    • 34247395303 scopus 로고    scopus 로고
    • National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data
    • Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2006;(162):1-209.
    • (2006) Vital Health Stat , vol.13 , Issue.162 , pp. 1-209
    • Kozak, L.J.1    DeFrances, C.J.2    Hall, M.J.3
  • 11
    • 0030987859 scopus 로고    scopus 로고
    • The effect of hip fracture on mortality, hospitalization, and functional status: A prospective study
    • Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997;87(3):398-403.
    • (1997) Am J Public Health , vol.87 , Issue.3 , pp. 398-403
    • Wolinsky, F.D.1    Fitzgerald, J.F.2    Stump, T.E.3
  • 12
    • 0036799693 scopus 로고    scopus 로고
    • Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study
    • Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ. Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002;50(10):1644-1650.
    • (2002) J Am Geriatr Soc , vol.50 , Issue.10 , pp. 1644-1650
    • Leibson, C.L.1    Tosteson, A.N.2    Gabriel, S.E.3    Ransom, J.E.4    Melton, L.J.5
  • 13
    • 0029052801 scopus 로고
    • Late physical and functional effects of osteoporotic fracture in women: The Rancho Bernardo Study
    • Greendale GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Geriatr Soc. 1995;43(9):955-961.
    • (1995) J Am Geriatr Soc , vol.43 , Issue.9 , pp. 955-961
    • Greendale, G.A.1    Barrett-Connor, E.2    Ingles, S.3    Haile, R.4
  • 14
    • 0033553866 scopus 로고    scopus 로고
    • Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group
    • Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159(11):1215-1220.
    • (1999) Arch Intern Med , vol.159 , Issue.11 , pp. 1215-1220
    • Kado, D.M.1    Browner, W.S.2    Palermo, L.3    Nevitt, M.C.4    Genant, H.K.5    Cummings, S.R.6
  • 15
    • 1342268230 scopus 로고    scopus 로고
    • Mortality after osteoporotic fractures
    • Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38-42.
    • (2004) Osteoporos Int , vol.15 , Issue.1 , pp. 38-42
    • Johnell, O.1    Kanis, J.A.2    Oden, A.3
  • 16
    • 0030668668 scopus 로고    scopus 로고
    • Excess mortality attributable to hip fracture in white women aged 70 years and older
    • Magaziner J, Lydick E, Hawkes W, et al. Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health. 1997;87(10):1630-1636.
    • (1997) Am J Public Health , vol.87 , Issue.10 , pp. 1630-1636
    • Magaziner, J.1    Lydick, E.2    Hawkes, W.3
  • 19
    • 44349159586 scopus 로고    scopus 로고
    • Osteoporosis medication use in nursing home patients with fractures in 1 US state
    • Parikh S, Mogun H, Avorn J, Solomon DH. Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch Intern Med. 2008;168(10):1111-1115.
    • (2008) Arch Intern Med , vol.168 , Issue.10 , pp. 1111-1115
    • Parikh, S.1    Mogun, H.2    Avorn, J.3    Solomon, D.H.4
  • 20
    • 27144523508 scopus 로고    scopus 로고
    • Trends and determinants of antiresorptive drug use for osteoporosis among elderly women
    • Perreault S, Dragomir A, Desgagne A, et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf. 2005;14(10):685-695.
    • (2005) Pharmacoepidemiol Drug Saf , vol.14 , Issue.10 , pp. 685-695
    • Perreault, S.1    Dragomir, A.2    Desgagne, A.3
  • 21
    • 0037394055 scopus 로고    scopus 로고
    • Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures
    • Neuner JM, Zimmer JK, Hamel MB. Diagnosis and treatment of osteoporosis in patients with vertebral compression fractures. J Am Geriatr Soc. 2003;51(4):483-491.
    • (2003) J Am Geriatr Soc , vol.51 , Issue.4 , pp. 483-491
    • Neuner, J.M.1    Zimmer, J.K.2    Hamel, M.B.3
  • 22
    • 25144508085 scopus 로고    scopus 로고
    • Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers
    • Jachna CM, Shireman TI, Whittle J, Ellerbeck EF, Rigler SK. Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers. J Am Geriatr Soc. 2005;53(8):1275-1281.
    • (2005) J Am Geriatr Soc , vol.53 , Issue.8 , pp. 1275-1281
    • Jachna, C.M.1    Shireman, T.I.2    Whittle, J.3    Ellerbeck, E.F.4    Rigler, S.K.5
  • 23
    • 33847637558 scopus 로고    scopus 로고
    • Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture
    • Colon-Emeric C, Lyles KW, Levine DA, et al. Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int. 2007;18(4):553-559.
    • (2007) Osteoporos Int , vol.18 , Issue.4 , pp. 553-559
    • Colon-Emeric, C.1    Lyles, K.W.2    Levine, D.A.3
  • 24
    • 34548425595 scopus 로고    scopus 로고
    • Use of osteoporosis medications in older nursing facility residents
    • Wright RM. Use of osteoporosis medications in older nursing facility residents. J Am Med Dir Assoc. 2007;8(7):453-457.
    • (2007) J Am Med Dir Assoc , vol.8 , Issue.7 , pp. 453-457
    • Wright, R.M.1
  • 25
    • 28644439896 scopus 로고    scopus 로고
    • Determinants of skeletal fragility
    • Bouxsein ML. Determinants of skeletal fragility. Best Pract Res Clin Rheumatol. 2005;19(6):897-911.
    • (2005) Best Pract Res Clin Rheumatol , vol.19 , Issue.6 , pp. 897-911
    • Bouxsein, M.L.1
  • 27
    • 11844268149 scopus 로고    scopus 로고
    • Increased falling as a risk factor for fracture among older women: The study of osteoporotic fractures
    • Schwartz AV, Nevitt MC, Brown BW, Jr, Kelsey JL. Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures. Am J Epidemiol. 2005;161(2):180-185.
    • (2005) Am J Epidemiol , vol.161 , Issue.2 , pp. 180-185
    • Schwartz, A.V.1    Nevitt, M.C.2    Brown Jr, B.W.3    Kelsey, J.L.4
  • 28
    • 34047113324 scopus 로고    scopus 로고
    • Infl uence of fall related factors and bone strength on fracture risk in the frail elderly
    • Sambrook PN, Cameron ID, Chen JS, et al. Infl uence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int. 2007;18(5):603-610.
    • (2007) Osteoporos Int , vol.18 , Issue.5 , pp. 603-610
    • Sambrook, P.N.1    Cameron, I.D.2    Chen, J.S.3
  • 29
    • 66349137742 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. (2006) [updated 2008 Nov 18; cited 2009 Jan 9]. Available from: www.cdc.gov/ncipc/wisqars.
    • Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) [online]. (2006) [updated 2008 Nov 18; cited 2009 Jan 9]. Available from: www.cdc.gov/ncipc/wisqars.
  • 30
    • 0025727281 scopus 로고
    • Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group
    • Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991;324(19):1326-1331.
    • (1991) N Engl J Med , vol.324 , Issue.19 , pp. 1326-1331
    • Grisso, J.A.1    Kelsey, J.L.2    Strom, B.L.3
  • 31
    • 33847249451 scopus 로고    scopus 로고
    • Risk factors associated with the occurrence of fractures in US nursing homes: Resident and facility characteristics and prescription medications
    • Spector W, Shaffer T, Potter DE, Correa-de-Araujo R, Rhona Limcangco M. Risk factors associated with the occurrence of fractures in US nursing homes: resident and facility characteristics and prescription medications. J Am Geriatr Soc. 2007;55(3):327-333.
    • (2007) J Am Geriatr Soc , vol.55 , Issue.3 , pp. 327-333
    • Spector, W.1    Shaffer, T.2    Potter, D.E.3    Correa-de-Araujo, R.4    Rhona Limcangco, M.5
  • 32
    • 0031972975 scopus 로고    scopus 로고
    • Epidemiology of medication-related falls and fractures in the elderly
    • Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging. 1998;12(1):43-53.
    • (1998) Drugs Aging , vol.12 , Issue.1 , pp. 43-53
    • Cumming, R.G.1
  • 33
    • 0035544371 scopus 로고    scopus 로고
    • Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly
    • Wei TS, Hu CH, Wang SH, Hwang KL. Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly. Osteoporos Int. 2001;12(12):1050-1055.
    • (2001) Osteoporos Int , vol.12 , Issue.12 , pp. 1050-1055
    • Wei, T.S.1    Hu, C.H.2    Wang, S.H.3    Hwang, K.L.4
  • 34
    • 0027515204 scopus 로고
    • Type of fall and risk of hip and wrist fractures: The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group
    • Nevitt MC, Cummings SR. Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 1993;41(11): 1226-1234.
    • (1993) J Am Geriatr Soc , vol.41 , Issue.11 , pp. 1226-1234
    • Nevitt, M.C.1    Cummings, S.R.2
  • 35
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D deficiency
    • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
    • (2007) N Engl J Med , vol.357 , Issue.3 , pp. 266-281
    • Holick, M.F.1
  • 36
    • 33846693086 scopus 로고    scopus 로고
    • Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D
    • Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc. 2007;8(2):71-75.
    • (2007) J Am Med Dir Assoc , vol.8 , Issue.2 , pp. 71-75
    • Hamid, Z.1    Riggs, A.2    Spencer, T.3    Redman, C.4    Bodenner, D.5
  • 38
    • 0034889433 scopus 로고    scopus 로고
    • Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
    • Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477-501.
    • (2001) Endocr Rev , vol.22 , Issue.4 , pp. 477-501
    • Lips, P.1
  • 39
    • 0032796638 scopus 로고    scopus 로고
    • Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
    • Sahota O, Masud T, San P, Hosking DJ. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf). 1999;51(2):217-221.
    • (1999) Clin Endocrinol (Oxf) , vol.51 , Issue.2 , pp. 217-221
    • Sahota, O.1    Masud, T.2    San, P.3    Hosking, D.J.4
  • 40
    • 0036201198 scopus 로고    scopus 로고
    • Vitamin D deficiency, muscle function, and falls in elderly people
    • Janssen HCJP, Samson MM, Verhaar HJJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002;75(4): 611-615.
    • (2002) Am J Clin Nutr , vol.75 , Issue.4 , pp. 611-615
    • Janssen, H.C.J.P.1    Samson, M.M.2    Verhaar, H.J.J.3
  • 41
    • 0032827408 scopus 로고    scopus 로고
    • Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel
    • Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999;47(10):1195-1201.
    • (1999) J Am Geriatr Soc , vol.47 , Issue.10 , pp. 1195-1201
    • Stein, M.S.1    Wark, J.D.2    Scherer, S.C.3
  • 42
    • 66349103184 scopus 로고    scopus 로고
    • US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General In: Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004:1-436.
    • US Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General In: Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004:1-436.
  • 43
    • 30944448208 scopus 로고    scopus 로고
    • Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women
    • Schousboe JT, Ensrud KE, Nyman JA, Melton LJ, 3rd, Kane RL. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc. 2005;53(10):1697-1704.
    • (2005) J Am Geriatr Soc , vol.53 , Issue.10 , pp. 1697-1704
    • Schousboe, J.T.1    Ensrud, K.E.2    Nyman, J.A.3    Melton 3rd, L.J.4    Kane, R.L.5
  • 44
    • 34547755634 scopus 로고    scopus 로고
    • Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men
    • Schousboe JT, Taylor BC, Fink HA, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA. 2007;298(6):629-637.
    • (2007) JAMA , vol.298 , Issue.6 , pp. 629-637
    • Schousboe, J.T.1    Taylor, B.C.2    Fink, H.A.3
  • 45
    • 0037125875 scopus 로고    scopus 로고
    • Screening for postmenopausal osteoporosis: A review of the evidence for the US Preventive Services Task Force
    • Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137(6):529-541.
    • (2002) Ann Intern Med , vol.137 , Issue.6 , pp. 529-541
    • Nelson, H.D.1    Helfand, M.2    Woolf, S.H.3    Allan, J.D.4
  • 46
    • 44649120398 scopus 로고    scopus 로고
    • European guidance for the diagnosis and management of osteoporosis in postmenopausal women
    • Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19(4):399-428.
    • (2008) Osteoporos Int , vol.19 , Issue.4 , pp. 399-428
    • Kanis, J.A.1    Burlet, N.2    Cooper, C.3
  • 47
    • 42649112056 scopus 로고    scopus 로고
    • Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11(1):75-91.
    • Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11(1):75-91.
  • 49
    • 29044435582 scopus 로고    scopus 로고
    • Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
    • King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporos Int. 2005;16(12): 1545-1557.
    • (2005) Osteoporos Int , vol.16 , Issue.12 , pp. 1545-1557
    • King, A.B.1    Saag, K.G.2    Burge, R.T.3    Pisu, M.4    Goel, N.5
  • 50
    • 46249101901 scopus 로고    scopus 로고
    • Longitudinal trends in use of bone mass measurement among older americans, 1999-2005
    • Curtis JR, Carbone L, Cheng H, et al. Longitudinal trends in use of bone mass measurement among older americans, 1999-2005. J Bone Miner Res. 2008;23(7):1061-1067.
    • (2008) J Bone Miner Res , vol.23 , Issue.7 , pp. 1061-1067
    • Curtis, J.R.1    Carbone, L.2    Cheng, H.3
  • 51
    • 33846226395 scopus 로고    scopus 로고
    • Adherence of academic geriatric practitioners to osteoporosis screening guidelines
    • McNally DN, Kenny AM, Smith JA. Adherence of academic geriatric practitioners to osteoporosis screening guidelines. Osteoporos Int. 2007;18(2):177-183.
    • (2007) Osteoporos Int , vol.18 , Issue.2 , pp. 177-183
    • McNally, D.N.1    Kenny, A.M.2    Smith, J.A.3
  • 52
    • 9444244524 scopus 로고    scopus 로고
    • The use of calcaneal ultrasound evaluation of bone mineral density in cognitively impaired seniors
    • Juby AG. The use of calcaneal ultrasound evaluation of bone mineral density in cognitively impaired seniors. J Am Med Dir Assoc. 2004;5(6):377-381.
    • (2004) J Am Med Dir Assoc , vol.5 , Issue.6 , pp. 377-381
    • Juby, A.G.1
  • 53
    • 42649144128 scopus 로고    scopus 로고
    • Quantitative ultrasound in the management of osteoporosis: The 2007 ISCD Official Positions
    • Krieg MA, Barkmann R, Gonnelli S, et al. Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom. 2008;11:163-187.
    • (2008) J Clin Densitom , vol.11 , pp. 163-187
    • Krieg, M.A.1    Barkmann, R.2    Gonnelli, S.3
  • 54
  • 55
    • 0038350758 scopus 로고    scopus 로고
    • Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D
    • Elliott ME, Binkley NC, Carnes M, et al. Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy. 2003;23(6):702-710.
    • (2003) Pharmacotherapy , vol.23 , Issue.6 , pp. 702-710
    • Elliott, M.E.1    Binkley, N.C.2    Carnes, M.3
  • 56
    • 66349096712 scopus 로고    scopus 로고
    • FRAX WHO Fracture Risk Assessment Tool. University of Sheffield UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases.; c2008 [cited 2009 Jan 9]. Available from: http://www.shef.ac.uk/FRAX/.
    • FRAX WHO Fracture Risk Assessment Tool. University of Sheffield UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases.; c2008 [cited 2009 Jan 9]. Available from: http://www.shef.ac.uk/FRAX/.
  • 57
    • 0030716177 scopus 로고    scopus 로고
    • Treatment with alendronate prevents fractures in women at highest risk: Results from the Fracture Intervention Trial
    • Ensrud KE, Black DM, Palermo L, et al. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med. 1997;157(22):2617-2624.
    • (1997) Arch Intern Med , vol.157 , Issue.22 , pp. 2617-2624
    • Ensrud, K.E.1    Black, D.M.2    Palermo, L.3
  • 58
    • 0035005348 scopus 로고    scopus 로고
    • Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention
    • Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc. 2001;49(5):664-672.
    • (2001) J Am Geriatr Soc , vol.49 , Issue.5 , pp. 664-672
  • 59
    • 34848906818 scopus 로고    scopus 로고
    • Quality indicators for falls and mobility problems in vulnerable elders
    • Chang JT, Ganz DA. Quality indicators for falls and mobility problems in vulnerable elders. J Am Geriatr Soc. 2007;55 Suppl 2:S327-S334.
    • (2007) J Am Geriatr Soc , vol.55 , Issue.SUPPL. 2
    • Chang, J.T.1    Ganz, D.A.2
  • 60
    • 34248574968 scopus 로고    scopus 로고
    • Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J Med. 2007;120(6):493 e1-e6.
    • Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J Med. 2007;120(6):493 e1-e6.
  • 61
    • 0037406769 scopus 로고    scopus 로고
    • Nonpharmacologic interventions. Exercise, fall prevention, and role of physical medicine
    • Sinaki M. Nonpharmacologic interventions. Exercise, fall prevention, and role of physical medicine. Clin Geriatr Med. 2003;19(2):337-359.
    • (2003) Clin Geriatr Med , vol.19 , Issue.2 , pp. 337-359
    • Sinaki, M.1
  • 63
    • 34548269021 scopus 로고    scopus 로고
    • Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association
    • Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1435-1445.
    • (2007) Med Sci Sports Exerc , vol.39 , Issue.8 , pp. 1435-1445
    • Nelson, M.E.1    Rejeski, W.J.2    Blair, S.N.3
  • 64
    • 2142713080 scopus 로고    scopus 로고
    • Effect of Vitamin D on falls: A meta-analysis
    • Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA. 2004;291(16): 1999-2006.
    • (2004) JAMA , vol.291 , Issue.16 , pp. 1999-2006
    • Bischoff-Ferrari, H.A.1    Dawson-Hughes, B.2    Willett, W.C.3
  • 65
    • 38849091377 scopus 로고    scopus 로고
    • Vitamin D supplementation to prevent falls In the elderly: Evidence and practical considerations
    • Fosnight SM, Zafirau WJ, Hazelett SE. Vitamin D supplementation to prevent falls In the elderly: evidence and practical considerations. Pharmacotherapy. 2008;28(2):225-234.
    • (2008) Pharmacotherapy , vol.28 , Issue.2 , pp. 225-234
    • Fosnight, S.M.1    Zafirau, W.J.2    Hazelett, S.E.3
  • 66
    • 29244461700 scopus 로고    scopus 로고
    • Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial
    • Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial.J Am Geriatr Soc. 2005;53(11):1881-1888.
    • (2005) J Am Geriatr Soc , vol.53 , Issue.11 , pp. 1881-1888
    • Flicker, L.1    MacInnis, R.J.2    Stein, M.S.3
  • 67
    • 33846513446 scopus 로고    scopus 로고
    • Impact of smoking cessation on bone mineral density in postmenopausal women
    • Oncken C, Prestwood K, Kleppinger A, Wang Y, Cooney J, Raisz L. Impact of smoking cessation on bone mineral density in postmenopausal women. J Womens Health. 2006;15(10):1141-1150.
    • (2006) J Womens Health , vol.15 , Issue.10 , pp. 1141-1150
    • Oncken, C.1    Prestwood, K.2    Kleppinger, A.3    Wang, Y.4    Cooney, J.5    Raisz, L.6
  • 68
    • 0033106426 scopus 로고    scopus 로고
    • Smoking, smoking cessation, and risk of hip fracture in women
    • Cornuz J, Feskanich D, Willett WC, Colditz GA. Smoking, smoking cessation, and risk of hip fracture in women. Am J Med. 1999;106(3):311-314.
    • (1999) Am J Med , vol.106 , Issue.3 , pp. 311-314
    • Cornuz, J.1    Feskanich, D.2    Willett, W.C.3    Colditz, G.A.4
  • 69
    • 24344441756 scopus 로고    scopus 로고
    • Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials
    • Sawka AM, Boulos P, Beattie K, et al. Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2005;16(12):1461-1474.
    • (2005) Osteoporos Int , vol.16 , Issue.12 , pp. 1461-1474
    • Sawka, A.M.1    Boulos, P.2    Beattie, K.3
  • 70
    • 34547167603 scopus 로고    scopus 로고
    • Efficacy of a hip protector to prevent hip fracture in nursing home residents: The HIP PRO randomized controlled trial
    • Kiel DP, Magaziner J, Zimmerman S, et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007;298(4):413-422.
    • (2007) JAMA , vol.298 , Issue.4 , pp. 413-422
    • Kiel, D.P.1    Magaziner, J.2    Zimmerman, S.3
  • 71
    • 21244436672 scopus 로고    scopus 로고
    • Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
    • O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118(7):778-781.
    • (2005) Am J Med , vol.118 , Issue.7 , pp. 778-781
    • O'Connell, M.B.1    Madden, D.M.2    Murray, A.M.3    Heaney, R.P.4    Kerzner, L.J.5
  • 72
    • 33845864487 scopus 로고    scopus 로고
    • Long-term proton pump inhibitor therapy and risk of hip fracture
    • Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24): 2947-2953.
    • (2006) JAMA , vol.296 , Issue.24 , pp. 2947-2953
    • Yang, Y.X.1    Lewis, J.D.2    Epstein, S.3    Metz, D.C.4
  • 73
    • 34548047185 scopus 로고    scopus 로고
    • Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis
    • Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-666.
    • (2007) Lancet , vol.370 , Issue.9588 , pp. 657-666
    • Tang, B.M.P.1    Eslick, G.D.2    Nowson, C.3    Smith, C.4    Bensoussan, A.5
  • 74
    • 18244397439 scopus 로고    scopus 로고
    • Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials
    • Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18): 2257-2264.
    • (2005) JAMA , vol.293 , Issue.18 , pp. 2257-2264
    • Bischoff-Ferrari, H.A.1    Willett, W.C.2    Wong, J.B.3    Giovannucci, E.4    Dietrich, T.5    Dawson-Hughes, B.6
  • 75
    • 30744449356 scopus 로고    scopus 로고
    • Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
    • Avenell AGW, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database of Systematic Reviews; 2005(3).
    • Cochrane Database of Systematic Reviews , vol.2005 , Issue.3
    • Avenell, A.G.W.1    Gillespie, L.D.2    O'Connell, D.L.3
  • 76
    • 34147164190 scopus 로고    scopus 로고
    • Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: Evidence from a comparative metaanalysis of randomized controlled trials
    • Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-1423.
    • (2007) J Clin Endocrinol Metab , vol.92 , Issue.4 , pp. 1415-1423
    • Boonen, S.1    Lips, P.2    Bouillon, R.3    Bischoff-Ferrari, H.A.4    Vanderschueren, D.5    Haentjens, P.6
  • 77
    • 33846569956 scopus 로고    scopus 로고
    • A higher dose of vitamin d reduces the risk of falls in nursing home residents: A randomized, multiple-dose study
    • Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55(2):234-239.
    • (2007) J Am Geriatr Soc , vol.55 , Issue.2 , pp. 234-239
    • Broe, K.E.1    Chen, T.C.2    Weinberg, J.3    Bischoff-Ferrari, H.A.4    Holick, M.F.5    Kiel, D.P.6
  • 78
    • 33748070519 scopus 로고    scopus 로고
    • Vitamin D supplementation and the prevention of fractures and falls: Results of a randomised trial in elderly people in residential accommodation
    • Law M, Withers H, Morris J, Anderson F. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing. 2006;35(5):482-486.
    • (2006) Age Ageing , vol.35 , Issue.5 , pp. 482-486
    • Law, M.1    Withers, H.2    Morris, J.3    Anderson, F.4
  • 79
    • 34247601023 scopus 로고    scopus 로고
    • Preventing fractures among older people living in institutional care: A pragmatic randomised double blind placebo controlled trial of vitamin D supplementation
    • Lyons RA, Johansen A, Brophy S, et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int. 2007;18(6):811-818.
    • (2007) Osteoporos Int , vol.18 , Issue.6 , pp. 811-818
    • Lyons, R.A.1    Johansen, A.2    Brophy, S.3
  • 80
    • 66349088865 scopus 로고    scopus 로고
    • World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK
    • National Osteoporosis Guideline Group, cited 2009 Jan 9, Available from
    • National Osteoporosis Guideline Group. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK; 2008. [cited 2009 Jan 9]; Available from: http://www.shef.ac.uk/ NOGG/.
    • (2008) Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
  • 81
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
    • Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535-1541.
    • (1996) Lancet , vol.348 , Issue.9041 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 82
    • 66349124530 scopus 로고    scopus 로고
    • US Food and Drug Administration. Center for Drug Evaluation and Research. FDA Alert: Information on Bisphosphonates[created: 2008 Jan 7, updated 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm.
    • US Food and Drug Administration. Center for Drug Evaluation and Research. FDA Alert: Information on Bisphosphonates[created: 2008 Jan 7, updated 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/infopage/bisphosphonates/default.htm.
  • 83
    • 33646836925 scopus 로고    scopus 로고
    • Narrative review: Bisphosphonates and osteonecrosis of the jaws
    • Woo SB, Hellstein JW, Kalmar JR. Narrative review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144(10): 753-761.
    • (2006) Ann Intern Med , vol.144 , Issue.10 , pp. 753-761
    • Woo, S.B.1    Hellstein, J.W.2    Kalmar, J.R.3
  • 85
    • 66349093770 scopus 로고    scopus 로고
    • US Food and Drug Administration. Center for Drug Evaluation and Research. Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates [created: 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_ 200811.htm.
    • US Food and Drug Administration. Center for Drug Evaluation and Research. Update of Safety Review Follow-up to the October 1, 2007 Early Communication about the Ongoing Safety Review of Bisphosphonates [created: 2008 Nov 12; cited 2009, Jan]. Available from: http://www.fda.gov/cder/drug/early_comm/bisphosphonates_update_ 200811.htm.
  • 86
    • 22844452550 scopus 로고    scopus 로고
    • Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women
    • Papapoulos SE, Quandt SA, Liberman UA, Hochberg MC, Thompson DE. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int. 2005;16(5):468-474.
    • (2005) Osteoporos Int , vol.16 , Issue.5 , pp. 468-474
    • Papapoulos, S.E.1    Quandt, S.A.2    Liberman, U.A.3    Hochberg, M.C.4    Thompson, D.E.5
  • 87
    • 12944291524 scopus 로고    scopus 로고
    • Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
    • Reginster J, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11(1):83-91.
    • (2000) Osteoporos Int , vol.11 , Issue.1 , pp. 83-91
    • Reginster, J.1    Minne, H.W.2    Sorensen, O.H.3
  • 88
    • 0035253489 scopus 로고    scopus 로고
    • Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group
    • McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001;344(5):333-340.
    • (2001) N Engl J Med , vol.344 , Issue.5 , pp. 333-340
    • McClung, M.R.1    Geusens, P.2    Miller, P.D.3
  • 89
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
    • Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282(14): 1344-1352.
    • (1999) JAMA , vol.282 , Issue.14 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3
  • 90
    • 4544262219 scopus 로고    scopus 로고
    • Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
    • Chesnut IC, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19(8):1241-1249.
    • (2004) J Bone Miner Res , vol.19 , Issue.8 , pp. 1241-1249
    • Chesnut, I.C.1    Skag, A.2    Christiansen, C.3
  • 91
    • 33745034449 scopus 로고    scopus 로고
    • Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study
    • Delmas PD, Adami S, Strugala C, et al. Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum. 2006;54(6):1838-1846.
    • (2006) Arthritis Rheum , vol.54 , Issue.6 , pp. 1838-1846
    • Delmas, P.D.1    Adami, S.2    Strugala, C.3
  • 92
    • 35748967004 scopus 로고    scopus 로고
    • Zoledronic acid and clinical fractures and mortality after hip fracture
    • Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799-1809.
    • (2007) N Engl J Med , vol.357 , Issue.18 , pp. 1799-1809
    • Lyles, K.W.1    Colon-Emeric, C.S.2    Magaziner, J.S.3
  • 93
    • 34247866550 scopus 로고    scopus 로고
    • Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
    • Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809-1822.
    • (2007) N Engl J Med , vol.356 , Issue.18 , pp. 1809-1822
    • Black, D.M.1    Delmas, P.D.2    Eastell, R.3
  • 94
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    • Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282(7):637-645.
    • (1999) JAMA , vol.282 , Issue.7 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 95
    • 33745876266 scopus 로고    scopus 로고
    • Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
    • Barrett-Connor E, Mosca L, Collins P, et al. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006;355(2):125-137.
    • (2006) N Engl J Med , vol.355 , Issue.2 , pp. 125-137
    • Barrett-Connor, E.1    Mosca, L.2    Collins, P.3
  • 96
    • 33746197958 scopus 로고    scopus 로고
    • Osteoporosis treatment: Raloxifene (Evista) and stroke mortality
    • Wooltorton E. Osteoporosis treatment: raloxifene (Evista) and stroke mortality. CMAJ. 2006;175(2):147.
    • (2006) CMAJ , vol.175 , Issue.2 , pp. 147
    • Wooltorton, E.1
  • 97
    • 0033829969 scopus 로고    scopus 로고
    • A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Group
    • Chesnut CH, 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med. 2000;109(4):267-276.
    • (2000) Am J Med , vol.109 , Issue.4 , pp. 267-276
    • Chesnut 3rd, C.H.1    Silverman, S.2    Andriano, K.3
  • 98
    • 25844438772 scopus 로고    scopus 로고
    • Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: A systematic review of randomized, controlled trials
    • Knopp JA, Diner BM, Blitz M, Lyritis GP, Rowe BH. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials. Osteoporos Int. 2005;16(10):1281-1290.
    • (2005) Osteoporos Int , vol.16 , Issue.10 , pp. 1281-1290
    • Knopp, J.A.1    Diner, B.M.2    Blitz, M.3    Lyritis, G.P.4    Rowe, B.H.5
  • 99
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19): 1434-1441.
    • (2001) N Engl J Med , vol.344 , Issue.19 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3
  • 100
    • 33947504500 scopus 로고    scopus 로고
    • Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: A randomized trial
    • Greenspan SL, Bone HG, Ettinger MP, et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007;146(5):326-339.
    • (2007) Ann Intern Med , vol.146 , Issue.5 , pp. 326-339
    • Greenspan, S.L.1    Bone, H.G.2    Ettinger, M.P.3
  • 101
    • 9144233479 scopus 로고    scopus 로고
    • The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    • Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350(5):459-468.
    • (2004) N Engl J Med , vol.350 , Issue.5 , pp. 459-468
    • Meunier, P.J.1    Roux, C.2    Seeman, E.3
  • 102
    • 21044447888 scopus 로고    scopus 로고
    • Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
    • Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab. 2005;90(5):2816-2822.
    • (2005) J Clin Endocrinol Metab , vol.90 , Issue.5 , pp. 2816-2822
    • Reginster, J.Y.1    Seeman, E.2    De Vernejoul, M.C.3
  • 104
    • 1842867053 scopus 로고    scopus 로고
    • Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial
    • Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291(14):1701-1712.
    • (2004) JAMA , vol.291 , Issue.14 , pp. 1701-1712
    • Anderson, G.L.1    Limacher, M.2    Assaf, A.R.3
  • 105
    • 0141705375 scopus 로고    scopus 로고
    • Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial
    • Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003;290(13):1729-1738.
    • (2003) JAMA , vol.290 , Issue.13 , pp. 1729-1738
    • Cauley, J.A.1    Robbins, J.2    Chen, Z.3
  • 106
    • 66349091128 scopus 로고    scopus 로고
    • Arias, E. National Vitals Statistic Report: United States Life Tables, 2003. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [created 2006 April 16, updated 2007 March 28; cited 2009 Jan 9] Available from: http://www.cdc.gov/nchs/data/statab/lewk3_2003.pdf.
    • Arias, E. National Vitals Statistic Report: United States Life Tables, 2003. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. [created 2006 April 16, updated 2007 March 28; cited 2009 Jan 9] Available from: http://www.cdc.gov/nchs/data/statab/lewk3_2003.pdf.
  • 107
    • 0037182042 scopus 로고    scopus 로고
    • Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis
    • Maricic M, Adachi JD, Sarkar S, Wu W, Wong M, Harper KD. Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis. Arch Intern Med. 2002;162(10):1140-1143.
    • (2002) Arch Intern Med , vol.162 , Issue.10 , pp. 1140-1143
    • Maricic, M.1    Adachi, J.D.2    Sarkar, S.3    Wu, W.4    Wong, M.5    Harper, K.D.6
  • 108
    • 11144354206 scopus 로고    scopus 로고
    • Efficacy of risedronate on clinical vertebral fractures within six months
    • Roux C, Seeman E, Eastell R, et al. Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004;20(4):433-439.
    • (2004) Curr Med Res Opin , vol.20 , Issue.4 , pp. 433-439
    • Roux, C.1    Seeman, E.2    Eastell, R.3
  • 109
    • 19044391760 scopus 로고    scopus 로고
    • Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures
    • Hochberg MC, Thompson DE, Black DM, et al. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005;20(6):971-976.
    • (2005) J Bone Miner Res , vol.20 , Issue.6 , pp. 971-976
    • Hochberg, M.C.1    Thompson, D.E.2    Black, D.M.3
  • 110
    • 4644346180 scopus 로고    scopus 로고
    • Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest old
    • Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc. 2004;52(11):1832-1839.
    • (2004) J Am Geriatr Soc , vol.52 , Issue.11 , pp. 1832-1839
    • Boonen, S.1    McClung, M.R.2    Eastell, R.3    El-Hajj Fuleihan, G.4    Barton, I.P.5    Delmas, P.6
  • 111
    • 66349119371 scopus 로고    scopus 로고
    • Cauley JA, Black D, Boonen SR, et al. Effect of Zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT. Osteoporos Int. 2007;18 (Suppl 2):S232. Abstract from the Seventh International Symposium on Osteoporosis: Translating Research into Clinical Practice. #P8.32.
    • Cauley JA, Black D, Boonen SR, et al. Effect of Zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT. Osteoporos Int. 2007;18 (Suppl 2):S232. Abstract from the Seventh International Symposium on Osteoporosis: Translating Research into Clinical Practice. #P8.32.
  • 112
    • 33744973067 scopus 로고    scopus 로고
    • Safety and efficacy of teriparatide in elderly women with established osteoporosis: Bone anabolic therapy from a geriatric perspective
    • Boonen S, Marin F, Mellstrom D, et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc. 2006;54(5):782-789.
    • (2006) J Am Geriatr Soc , vol.54 , Issue.5 , pp. 782-789
    • Boonen, S.1    Marin, F.2    Mellstrom, D.3
  • 113
    • 0037216436 scopus 로고    scopus 로고
    • The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
    • Marcus R, Wang O, Satterwhite J, Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res. 2003;18(1):18-23.
    • (2003) J Bone Miner Res , vol.18 , Issue.1 , pp. 18-23
    • Marcus, R.1    Wang, O.2    Satterwhite, J.3    Mitlak, B.4
  • 114
    • 33745494818 scopus 로고    scopus 로고
    • Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older
    • Seeman E, Vellas B, Benhamou C, et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res. 2006;21(7):1113-1120.
    • (2006) J Bone Miner Res , vol.21 , Issue.7 , pp. 1113-1120
    • Seeman, E.1    Vellas, B.2    Benhamou, C.3
  • 115
    • 0037150130 scopus 로고    scopus 로고
    • Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial
    • Greenspan SL, Schneider DL, McClung MR, et al. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Annals of Intern Med. 2002;136(10): 742-746.
    • (2002) Annals of Intern Med , vol.136 , Issue.10 , pp. 742-746
    • Greenspan, S.L.1    Schneider, D.L.2    McClung, M.R.3
  • 116
    • 0024309856 scopus 로고
    • Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures
    • Pun KK, Chan LW. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther. 1989;11(2):205-209.
    • (1989) Clin Ther , vol.11 , Issue.2 , pp. 205-209
    • Pun, K.K.1    Chan, L.W.2
  • 117
    • 0031255490 scopus 로고    scopus 로고
    • Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study
    • Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl. 1997;275:112-114.
    • (1997) Acta Orthop Scand Suppl , vol.275 , pp. 112-114
    • Lyritis, G.P.1    Paspati, I.2    Karachalios, T.3    Ioakimidis, D.4    Skarantavos, G.5    Lyritis, P.G.6
  • 118
    • 0037214255 scopus 로고    scopus 로고
    • The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
    • Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res. 2003;18(1):9-17.
    • (2003) J Bone Miner Res , vol.18 , Issue.1 , pp. 9-17
    • Orwoll, E.S.1    Scheele, W.H.2    Paul, S.3
  • 119
    • 23744484933 scopus 로고    scopus 로고
    • Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke
    • Sato Y, Iwamoto J, Kanoko T, Satoh K. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med. 2005;165(15):1743-1748.
    • (2005) Arch Intern Med , vol.165 , Issue.15 , pp. 1743-1748
    • Sato, Y.1    Iwamoto, J.2    Kanoko, T.3    Satoh, K.4
  • 120
    • 34147108671 scopus 로고    scopus 로고
    • Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease
    • Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68(12):911-915.
    • (2007) Neurology , vol.68 , Issue.12 , pp. 911-915
    • Sato, Y.1    Honda, Y.2    Iwamoto, J.3
  • 121
    • 33644616548 scopus 로고    scopus 로고
    • Efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 1-year study
    • Ringe JD, Faber H, Farahmand P, Dorst A. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int. 2006;26(5):427-431.
    • (2006) Rheumatol Int , vol.26 , Issue.5 , pp. 427-431
    • Ringe, J.D.1    Faber, H.2    Farahmand, P.3    Dorst, A.4
  • 122
    • 0141796739 scopus 로고    scopus 로고
    • The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
    • Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003;349(13):1216-1226.
    • (2003) N Engl J Med , vol.349 , Issue.13 , pp. 1216-1226
    • Finkelstein, J.S.1    Hayes, A.2    Hunzelman, J.L.3    Wyland, J.J.4    Lee, H.5    Neer, R.M.6
  • 123
    • 0034739277 scopus 로고    scopus 로고
    • Alendronate for the treatment of osteoporosis in men
    • Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343(9):604-610.
    • (2000) N Engl J Med , vol.343 , Issue.9 , pp. 604-610
    • Orwoll, E.1    Ettinger, M.2    Weiss, S.3
  • 124
    • 26444539825 scopus 로고    scopus 로고
    • Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age
    • Ettinger MP, Felsenberg D, Harris ST, et al. Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age. J Rheumatol. 2005;32(10):1968-1974.
    • (2005) J Rheumatol , vol.32 , Issue.10 , pp. 1968-1974
    • Ettinger, M.P.1    Felsenberg, D.2    Harris, S.T.3
  • 125
    • 33846899271 scopus 로고    scopus 로고
    • Compliance with osteoporosis drug therapy and risk of fracture
    • Weycker D, Macarios D, Edelsberg J, Oster G. Compliance with osteoporosis drug therapy and risk of fracture. Osteoporos Int. 2007;18(3):271-277.
    • (2007) Osteoporos Int , vol.18 , Issue.3 , pp. 271-277
    • Weycker, D.1    Macarios, D.2    Edelsberg, J.3    Oster, G.4
  • 126
    • 44949126427 scopus 로고    scopus 로고
    • Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
    • Blouin J, Dragomir A, Moride Y, Ste-Marie LG, Fernandes JC, Perreault S. Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol. 2008;66(1):117-127.
    • (2008) Br J Clin Pharmacol , vol.66 , Issue.1 , pp. 117-127
    • Blouin, J.1    Dragomir, A.2    Moride, Y.3    Ste-Marie, L.G.4    Fernandes, J.C.5    Perreault, S.6
  • 127
    • 33746821808 scopus 로고    scopus 로고
    • Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases
    • Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013-1022.
    • (2006) Mayo Clin Proc , vol.81 , Issue.8 , pp. 1013-1022
    • Siris, E.S.1    Harris, S.T.2    Rosen, C.J.3
  • 128
    • 42249109858 scopus 로고    scopus 로고
    • Use of bisphosphonates among women and risk of atrial fibrillation and flutter: Population based case-control study
    • Sorensen HT, Christensen S, Mehnert F, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ. 2008;336(7648):813-816.
    • (2008) BMJ , vol.336 , Issue.7648 , pp. 813-816
    • Sorensen, H.T.1    Christensen, S.2    Mehnert, F.3
  • 129
  • 130
    • 42949145038 scopus 로고    scopus 로고
    • Use of alendronate and risk of incident atrial fibrillation in women
    • Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med. 2008;168(8):826-831.
    • (2008) Arch Intern Med , vol.168 , Issue.8 , pp. 826-831
    • Heckbert, S.R.1    Li, G.2    Cummings, S.R.3    Smith, N.L.4    Psaty, B.M.5
  • 131
    • 33745249570 scopus 로고    scopus 로고
    • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial
    • Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295(23):2727-2741.
    • (2006) JAMA , vol.295 , Issue.23 , pp. 2727-2741
    • Vogel, V.G.1    Costantino, J.P.2    Wickerham, D.L.3
  • 132
    • 0036235019 scopus 로고    scopus 로고
    • Prevalence of low glomerular fi ltration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)
    • Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular fi ltration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13(5):1338-1349.
    • (2002) J Am Soc Nephrol , vol.13 , Issue.5 , pp. 1338-1349
    • Clase, C.M.1    Garg, A.X.2    Kiberd, B.A.3
  • 133
    • 33846527154 scopus 로고    scopus 로고
    • Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: The Rancho Bernardo study
    • Jassal SK, von Muhlen D, Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res. 2007;22(2):203-210.
    • (2007) J Bone Miner Res , vol.22 , Issue.2 , pp. 203-210
    • Jassal, S.K.1    von Muhlen, D.2    Barrett-Connor, E.3
  • 134
    • 28144453342 scopus 로고    scopus 로고
    • Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials
    • Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res. 2005;20(12):2105-2115.
    • (2005) J Bone Miner Res , vol.20 , Issue.12 , pp. 2105-2115
    • Miller, P.D.1    Roux, C.2    Boonen, S.3    Barton, I.P.4    Dunlap, L.E.5    Burgio, D.E.6
  • 135
    • 33845370793 scopus 로고    scopus 로고
    • Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
    • Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int. 2007;18(1):59-68.
    • (2007) Osteoporos Int , vol.18 , Issue.1 , pp. 59-68
    • Miller, P.D.1    Schwartz, E.N.2    Chen, P.3    Misurski, D.A.4    Krege, J.H.5
  • 136
    • 34249653663 scopus 로고    scopus 로고
    • Alendronate treatment in women with normal to severely impaired renal function: An analysis of the fracture intervention trial
    • Jamal SA, Bauer DC, Ensrud KE, et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res. 2007;22(4): 503-508.
    • (2007) J Bone Miner Res , vol.22 , Issue.4 , pp. 503-508
    • Jamal, S.A.1    Bauer, D.C.2    Ensrud, K.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.